Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Varied Growth Drivers Led Antipodes Global Value Strategy to Add Globus Medical (GMED) to Its Portfolio

Antipodes Partners recently published its “Antipodes Global Value Strategy” third-quarter 2025 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook. A copy of the letter can be downloaded here. In the quarter, global equities rose positively, supported by easing trade tensions, excitement around AI, and expectations of rate cuts by the Federal Reserve. Global equities gained +7.6% in USD and +6.4% in AUD, driven by central bank interest rate reductions, new US trade agreements, and strong corporate earnings. The Antipodes Global Value...